Process for the manufacture of HMG-CoA reductase inhibitory...

Details Process for the manufacture of HMG-CoA reductase inhibitory... Process for the manufacture of HMG-CoA reductase inhibitory...

2007-04-24

2007-04-24

Page, Thurman K. (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carboxylic acids and salts thereof

Reexamination Certificate

active

10504655

ABSTRACT:
The invention relates to a process for the manufacture of a compound of formula: (Formula I); or a salt, especially a pharmaceutically acceptable salt with a base, thereof or a lactone thereof wherein the element (a) represents —CH2—CH2— or —CH═CH— and R represents a cyclic radical.

REFERENCES:
patent: 4851427 (1989-07-01), Wareing
patent: 5273995 (1993-12-01), Roth
patent: 5399722 (1995-03-01), Beck et al.
patent: 5763688 (1998-06-01), Ikariya et al.
patent: 6184381 (2001-02-01), Ikariya et al.
patent: 6211412 (2001-04-01), Georg et al.
patent: 2002/0156289 (2002-10-01), Georg et al.
patent: 0 304 063 (1989-02-01), None
patent: 0 916 637 (1999-05-01), None
patent: 1 134 226 (2001-09-01), None
patent: 1 136 475 (2001-09-01), None
patent: WO 01/92223 (2001-12-01), None
patent: WO 02/008169 (2002-01-01), None
patent: WO 03/070717 (2003-08-01), None
Tetrahedron Letters, 45(30), 5845-5847; 2004.
Matsumura, Hashiguchi, Ikariya and Noyori, “Asymmetric Transfer Hydrogenation of α,β-Acetylenic Ketones”,J Am Chem Soc, vol. 119, No. 37, pp. 8738-8739 (1997).
Noyori and Ohkuma, “Asymmetric Catalysis by Architectural and Functional Molecular Engineering: Practical Chemo- and Stereoselective Hydrogenation of Ketones”,Angew Chem Int Ed, vol. 40, No. 1, pp. 40-73 (2001).
Noyori, Yamakawa and Hashiguchi, “Metal-Ligand Bifunctional Catalysis: A Nonclassical Mechanism for Asymmetric Hydrogen Transfer Between Alcohols and Carbonyl Compounds”,J Org Chem, vol. 66, No. 24, pp. 7931-7944 (2001).
Ohkuma et al., “Selective Hydrogenation of Benzophenones to Benzhydrols. Asymmetric Synthesis of Unsymmetrical Diarylmethanols”,Org Lett, vol. 2, No. 5, pp. 659-662 (2000).
Ohkuma et al., “Asymmetric Hydrogenation of Alkenyl, Cyclopropyl, and Aryl Ketones. RuCI2(xylbinap)(1,2-diamine) as a Precatalyst Exhibiting a Wide Scope”,J Am Chem Soc, vol. 120, No. 51, pp. 13529-13530 (1998).
Repic, Prasad and Lee, “The Story of Lescol: From Research to Production”,Org Process Res Dev, vol. 5, No. 5, pp. 519-527 (2001).
Suzuki et al., “First Systematic Chiral Syntheses of Two Pairs of Enantiomers with 3,5-Dihydroxyheptenoic Acid Chain, Associated with a Potent Synthetic Statin NK-104”,Bioorg Med Chem Lett, vol. 9, No. 20, pp. 2977-2982 (1999).

Affiliated with

Also associated with

Rating

Process for the manufacture of HMG-CoA reductase inhibitory... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for the manufacture of HMG-CoA reductase inhibitory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the manufacture of HMG-CoA reductase inhibitory... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3766598